|
Product complaint#: (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
3rd revision.Attune revision femur losening.Patient status/ outcome / consequences, was other medical intervention (e.G.X-rays, additional procedures, prescriptions, otc, revision) required: unknown, is the patient part of a clinical study: unknown, ip-01589849.Device property of none, device in possession of none, ip-01589850.Device property of none, device in possession of none, ip-01589851.Device property of none, device in possession of none, ip-01589852.Device property of none, device in possession of none, ip-01589853.Device property of none, device in possession of none, ip-01589854.Device property of none, device in possession of none, ip-01589855.Device property of none, device in possession of none, by checking this box i certify that all information that are known/available has been disclosed.If any new information will be made available, the additional information will be submitted through cst.True.
|